Viewing Study NCT03463057


Ignite Creation Date: 2025-12-24 @ 6:38 PM
Ignite Modification Date: 2025-12-29 @ 6:14 PM
Study NCT ID: NCT03463057
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-09-19
First Post: 2018-02-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: The Feasibility and Clinical Efficacy of Atezolizumab Consolidation Treatment in High Risk (IPI > 2) DLBCL
Sponsor: Stichting Hemato-Oncologie voor Volwassenen Nederland
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module